17-61685937-A-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_032043.3(BRIP1):āc.2804T>Gā(p.Val935Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,614,106 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032043.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251362Hom.: 1 AF XY: 0.000287 AC XY: 39AN XY: 135860
GnomAD4 exome AF: 0.000121 AC: 177AN: 1461768Hom.: 1 Cov.: 31 AF XY: 0.000168 AC XY: 122AN XY: 727184
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:2Benign:1Other:1
- -
- -
DNA sequence analysis of the BRIP1 gene demonstrated a sequence change, c.2804T>G, in exon 19 that results in an amino acid change, p.Val935Gly. This sequence change does not appear to have been previously described in patients with BRIP1-related disorders and has been described in the gnomAD database with a frequency of 0.14% in South Asian populatons (dbSNP rs4988356). The p.Val935Gly change affects a poorly conserved amino acid residue located in a domain of the BRIP1 protein that is not known to be functional. The p.Val935Gly substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to the lack of functional studies, the clinical significance of the p.Val935Gly change remains unknown at this time. -
- -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:2
- -
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Fanconi anemia complementation group J Uncertain:1
- -
Ovarian neoplasm;C1836860:Fanconi anemia complementation group J Uncertain:1
- -
not provided Uncertain:1
Observed in an individual with breast cancer (Rutter 2003); Identified at similar frequency in breast cancer cases and controls in a large case-control study (p=0.51) (Easton 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Also known as BRIP1 c.2945T>G; This variant is associated with the following publications: (PMID: 12872252, 24728327, 26921362) -
Familial cancer of breast Uncertain:1
This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. -
Breast and/or ovarian cancer Benign:1
- -
Familial cancer of breast;C1836860:Fanconi anemia complementation group J Benign:1
- -
Inherited ovarian cancer (without breast cancer) Benign:1
BS1_Strong,BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at